End-stage Heart Failure: Clinical Trials

1 completed, 1 withdrawn. 2 Phase 2.

By phase and status

Phase	Trials	Status
Phase 2	2	Completed 1, Withdrawn 1

Follow End-stage Heart Failure: new trials by email Literature Review of End-stage Heart Failure trials Research Report on End-stage Heart Failure

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Acute Reno-Cardiac Action of Dapagliflozin In Advanced Heart Failure Patients on Heart Transplant Waiting List Dapagliflozin 10mg, Placebo - End-stage Heart Failure	Phase 2	Withdrawn	Hospices Civils de Lyon		2022-09-01	2023-08-07
VentrAssistTM LVAD as a Bridge to Cardiac Transplantation - Feasibility Trial VentrAssist Left Ventricular Assist Device - End-Stage Heart Failure, Cardiomyopathies	Phase 2	Completed	Ventracor	30	2005-07-01	2008-01-17

Narrower conditions

Cardio-Renal Syndrome (1)  ·  Cardiomyopathies (1)

Broader conditions

Cardiovascular Diseases (2)  ·  Heart Diseases (2)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Heart Failure (1)  ·  Kidney Diseases (1)  ·  Male Urogenital Diseases (1)  ·  Renal Insufficiency (1)  ·  Urogenital Diseases (1)  ·  Urologic Diseases (1)

Interventions

dapagliflozin (1)

Sponsors

Hospices Civils de Lyon (1)  ·  Ventracor (1)

Countries

France (1)  ·  United States (1)